Recent advancements in medical science have opened new avenues for treating chronic diseases. A group of Chinese scientists has reportedly cured a 25-year-old woman with type 1 diabetes through a groundbreaking cell transplant procedure. This case, claimed to be the first of its kind globally, marks a significant milestone in diabetes treatment and may offer… Read More »
Right on the heels of not one, but two CAR-T approvals in the U.S., Bristol Myers Squibb is bolstering its commercial cell therapy ambitions on the other side of the Atlantic. The company on Thursday pegged Leiden, Netherlands, as the home of its first cell therapy factory in Europe and its fifth worldwide. With planning for site design and… Read More »
By Layal Liverpool We don’t know why some people who have allergies lose their sense of smellRuslan Nassyrov / Alamy Stock Photo Mice have tens of thousands of chemical sensing nose cells that can cause an allergic reaction. Researchers say this discovery could help us understand how the immune system reacts to inhaled allergens and… Read More »
FDA Approves Oxbryta (voxelotor) for the Treatment of Sickle Cell Disease Print this page SOUTH SAN FRANCISCO, Calif., Nov. 25, 2019 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Oxbryta™ (voxelotor) tablets for the treatment of sickle cell disease (SCD) in adults and children… Read More »